{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:32:24Z","timestamp":1792211544463,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,8]]},"DOI":"10.7759\/cureus.66437","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T12:27:05Z","timestamp":1723120025000},"source":"Crossref","is-referenced-by-count":2,"title":["Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease Associated With Ocular Graft-Versus-Host Disease"],"prefix":"10.7759","author":[{"given":"Calvin W","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison L","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan S","family":"Gombos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Chronic graft-versus-host disease","volume":"5","author":"Atkinson K","year":"1990","unstructured":"Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant. 1990, 5:69-82.","journal-title":"Bone Marrow Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198901000-00012","article-title":"Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease","volume":"47","author":"Ferrara JL","year":"1989","unstructured":"Ferrara JL, Guillen FJ, van Dijken PJ, Marion A, Murphy GF, Burakoff SJ. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation. 1989, 47:50-4. 10.1097\/00007890-198901000-00012","journal-title":"Transplantation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(83)34604-2","article-title":"Ocular manifestations of graft-vs-host disease","volume":"90","author":"Franklin RM","year":"1983","unstructured":"Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983, 90:4-13. 10.1016\/s0161-6420(83)34604-2","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-6-707","article-title":"Scleroderma, Sj\u00f6gren-like syndrome, and chronic graft-versus-host disease","volume":"87","author":"Lawley TJ","year":"1977","unstructured":"Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB. Scleroderma, Sj\u00f6gren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med. 1977, 87:707-9. 10.7326\/0003-4819-87-6-707","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-6-703","article-title":"Sj\u00f6gren-type syndrome after allogeneic bone-marrow transplantation","volume":"87","author":"Gratwohl AA","year":"1977","unstructured":"Gratwohl AA, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB, Deisseroth AB. Sj\u00f6gren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med. 1977, 87:703-6. 10.7326\/0003-4819-87-6-703","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090150102031","article-title":"The eye in bone marrow transplantation. VI. Retinal complications","volume":"112","author":"Coskuncan NM","year":"1994","unstructured":"Coskuncan NM, Jabs DA, Dunn JP, Haller JA, Green WR, Vogelsang GB, Santos GW. The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol. 1994, 112:372-9. 10.1001\/archopht.1994.01090150102031","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2013.06.007","article-title":"Ocular manifestations of graft-versus-host disease","volume":"27","author":"Nassar A","year":"2013","unstructured":"Nassar A, Tabbara KF, Aljurf M. Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol. 2013, 27:215-22. 10.1016\/j.sjopt.2013.06.007","journal-title":"Saudi J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45136","article-title":"Topical spironolactone in the treatment of ocular graft-versus-host disease","volume":"15","author":"Wong CW","year":"2023","unstructured":"Wong CW, Yang AA, Liu CY, Watsky MA, Lu X, Le HL, Yee RW. Topical spironolactone in the treatment of ocular graft-versus-host disease. Cureus. 2023, 15:e45136. 10.7759\/cureus.45136","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.02.008","article-title":"Efficacy and safety of 1% progesterone gel to the forehead for ocular chronic graft-versus-host disease","volume":"27","author":"Luo ZK","year":"2021","unstructured":"Luo ZK, Domenech-Estarellas EA, Han A, et al.. Efficacy and safety of 1% progesterone gel to the forehead for ocular chronic graft-versus-host disease. Transplant Cell Ther. 2021, 27:433.e1-8. 10.1016\/j.jtct.2021.02.008","journal-title":"Transplant Cell Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2019.03.010","article-title":"Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: implications for novel biomarkers and therapeutic strategies","volume":"17","author":"An S","year":"2019","unstructured":"An S, Raju I, Surenkhuu B, et al.. Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: implications for novel biomarkers and therapeutic strategies. Ocul Surf. 2019, 17:589-614. 10.1016\/j.jtos.2019.03.010","journal-title":"Ocul Surf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/2515841419870366","article-title":"Lifitegrast: a novel drug for patients with dry eye disease","volume":"11","author":"Haber SL","year":"2019","unstructured":"Haber SL, Benson V, Buckway CJ, Gonzales JM, Romanet D, Scholes B. Lifitegrast: a novel drug for patients with dry eye disease. Ther Adv Ophthalmol. 2019, 11:2515841419870366. 10.1177\/2515841419870366","journal-title":"Ther Adv Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9110153","article-title":"Role of LFA-1 and ICAM-1 in cancer","volume":"9","author":"Reina M","year":"2017","unstructured":"Reina M, Espel E. Role of LFA-1 and ICAM-1 in cancer. Cancers (Basel). 2017, 9:153. 10.3390\/cancers9110153","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.08.001","article-title":"Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study","volume":"122","author":"Tauber J","year":"2015","unstructured":"Tauber J, Karpecki P, Latkany R, et al.. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study. Ophthalmology. 2015, 122:2423-31. 10.1016\/j.ophtha.2015.08.001","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg DA","year":"2007","unstructured":"Schaumberg DA, Gulati A, Mathers WD, et al.. Development and validation of a short global dry eye symptom index. Ocul Surf. 2007, 5:50-7. 10.1016\/S1542-0124(12)70053-8","journal-title":"Ocul Surf"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.98800","article-title":"Examination for Dry Eyes","author":"Wahyu T","year":"2021","unstructured":"Wahyu T. Examination for Dry Eyes. IntechOpen, 2021. 10.5772\/intechopen.98800"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2019.01.004","article-title":"Review and analysis of grading scales for ocular surface staining","volume":"17","author":"Begley C","year":"2019","unstructured":"Begley C, Caffery B, Chalmers R, Situ P, Simpson T, Nelson JD. Review and analysis of grading scales for ocular surface staining. Ocul Surf. 2019, 17:208-20. 10.1016\/j.jtos.2019.01.004","journal-title":"Ocul Surf"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e318157ac9e","article-title":"The development of validated bulbar redness grading scales","volume":"84","author":"Schulze MM","year":"2007","unstructured":"Schulze MM, Jones DA, Simpson TL. The development of validated bulbar redness grading scales. Optom Vis Sci. 2007, 84:976-83. 10.1097\/OPX.0b013e318157ac9e","journal-title":"Optom Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/srep03419","article-title":"International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I)","volume":"3","author":"Ogawa Y","year":"2013","unstructured":"Ogawa Y, Kim SK, Dana R, et al.. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013, 3:3419. 10.1038\/srep03419","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40135-014-0041-9","article-title":"MGD diagnosis","volume":"2","author":"Arita R","year":"2014","unstructured":"Arita R, Zavala M, Yee R. MGD diagnosis. Curr Ophthalmol Rep. 2014, 2:49-57. 10.1007\/s40135-014-0041-9","journal-title":"Curr Ophthalmol Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.02.037","article-title":"Comparison of two questionnaires for dry eye symptom assessment: the ocular surface disease Index and the symptom assessment in dry eye","volume":"122","author":"Amparo F","year":"2015","unstructured":"Amparo F, Schaumberg DA, Dana R. Comparison of two questionnaires for dry eye symptom assessment: the ocular surface disease Index and the symptom assessment in dry eye. Ophthalmology. 2015, 122:1498-503. 10.1016\/j.ophtha.2015.02.037","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2023.2211249","article-title":"Correlation and level of agreement between the ocular surface disease Index and the symptom assessment in dry eye questionnaires: a survey-based study","volume":"48","author":"Rodriguez-Garcia A","year":"2023","unstructured":"Rodriguez-Garcia A, Ruiz-Lozano RE, Bustamante-Arias A, Pantaleon-Garcia J, Hernandez-Quintela E, Navas A. Correlation and level of agreement between the ocular surface disease Index and the symptom assessment in dry eye questionnaires: a survey-based study. Curr Eye Res. 2023, 48:788-98. 10.1080\/02713683.2023.2211249","journal-title":"Curr Eye Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269473-effects-and-safety-of-5-lifitegrast-ophthalmic-solution-in-patients-with-dry-eye-disease-associated-with-ocular-graft-versus-host-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T12:27:15Z","timestamp":1723120035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269473-effects-and-safety-of-5-lifitegrast-ophthalmic-solution-in-patients-with-dry-eye-disease-associated-with-ocular-graft-versus-host-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.66437","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}